Skip to main content
. 2019 Mar 13;4(1):62–72. doi: 10.1089/can.2018.0027

FIG. 3.

FIG. 3.

Cost-effectiveness acceptability curve from probabilistic sensitivity analysis. Percentage of iterations, in which a given treatment strategy is most cost-effective, was plotted against escalating willingness-to-pay thresholds. In our model, cannabis-containing strategies were most cost-effective at willingness-to-pay thresholds of approximately $60,000 per QALY gained and above.